- Home
- PCRX vs AMAL Comparison
PCRX vs AMAL Comparison
Compare PCRX & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCRX | AMAL |
|---|---|---|
| Founded | 2006 | 1923 |
| Country | United States | United States |
| Employees | N/A | 450 |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PCRX | AMAL |
|---|---|---|
| Price | $23.52 | $40.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $30.25 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 515.7K | 114.5K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.07 | ★ 0.84 |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $6.78 | $21.18 |
| Revenue Next Year | $8.54 | $6.55 |
| P/E Ratio | $336.79 | ★ $48.10 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $25.13 |
| 52 Week High | $27.64 | $44.01 |
Technical Indicators
Market Signals| Indicator | PCRX | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 50.63 | 46.36 |
| Support Level | $23.74 | $36.50 |
| Resistance Level | $24.20 | $40.89 |
| Average True Range (ATR) | 1.22 | 0.97 |
| MACD | -0.17 | -0.22 |
| Stochastic Oscillator | 33.16 | 14.49 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.